D. Corzo

发表

HLA associations in clozapine-induced agranulocytosis

J. Lieberman, J. Yunis, D. Corzo, 1995 .

Fractures in children with Pompe disease: a potentiallong-term complication

D. Frush, Yuan-Tsong Chen, C. Morgan, 2007, Pediatric Radiology.

Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.

H. Moser, A. Moser, C. Zeiss, 2002, American journal of human genetics.

Treatment of metastatic breast cancer with 𝑛𝑎𝑏-paclitaxel in the community practice setting: a US Oncology survey.

D. Patt, D. Corzo, D. Rembert, 2015, The Journal of community and supportive oncology.

A randomized study of alglucosidase alfa in late-onset Pompe's disease.

A. Pestronk, P. Laforêt, C. Morgan, 2010, The New England journal of medicine.

Efficacy and Safety of Three Bortezomib-Based Combinations in Elderly, Newly Diagnosed Multiple Myeloma Patients: Results From All Randomized Patients in the Community-Based, Phase 3b UPFRONT Study

J. Reeves, I. Flinn, R. Neuwirth, 2011 .

agranulocytosis in two different ethnic groups HSP70- 2 variants is associated with clozapine-induced The major histocompatibility complex region marked by HSP70-1 and

J. Yunis, E. Yunis, D. Corzo, 2011 .

The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maintenance treatment.

L. Garrison, H. van de Velde, M. Duh, 2013, The oncologist.

CHINESE HAMSTER OVARY CELL-DERIVED RECOMBINANT HUMAN ACID α -GLUCOSIDASE IN INFANTILE-ONSET POMPE DISEASE

G. Herman, T. Voit, A. Amalfitano, 2009 .

Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker

D. Millington, D. Bali, B. Thurberg, 2009, Genetics in Medicine.

Nephrotic Syndrome Complicating α-Glucosidase Replacement Therapy for Pompe Disease

J. Phillips, Yuan-Tsong Chen, A. Fogo, 2004, Pediatrics.

Recombinant human acid α-glucosidase

B. Byrne, J. Clancy, H. Mandel, 2007, Neurology.

Alglucosidase Alfa (Myozyme ®) in Infants and Children with Rapidly Progressive Pompe Disease

B. Byrne, H. Mandel, W. Hwu, 2008 .

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease

B. Byrne, H. Mandel, N. Leslie, 2009, Genetics in Medicine.

Cardiac arrhythmias following anesthesia induction in infantile‐onset Pompe disease: a case series

A. Ross, C. Morgan, Jennifer S. Li, 2007, Paediatric anaesthesia.

Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease

J. Clancy, H. Mandel, N. Leslie, 2009, Pediatric Research.

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.

B. Byrne, J. Clancy, H. Mandel, 2007, Neurology.

Interim Results from a Dose Escalating Study of AMT-060 (AAV5-hFIX) Gene Transfer in Adult Patients with Severe Hemophilia B

E. Seifried, G. Castaman, R. Klamroth, 2016 .

Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.

B. Nordestgaard, E. Steinhagen-Thiessen, H. Petry, 2016, Journal of clinical lipidology.

Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf–Hirschhorn Syndrome

S. South, P. Hammond, M. Suttie, 2013, European Journal of Human Genetics.

Identification of critical regions for clinical features of distal 10q deletion syndrome

Z. Ou, S. Cheung, D. Peiffer, 2009, Clinical genetics.

Sibling phenotype concordance in classical infantile Pompe disease

Yuan-Tsong Chen, Jennifer S. Li, P. Kishnani, 2007, American journal of medical genetics. Part A.

Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.

D. Gaudet, D. Brisson, G. Iotti, 2016, Human gene therapy.

Safety and efficacy of nab-paclitaxel (nab-P) in patients (pts) with metastatic breast cancer (MBC): Real-world results from a U.S. health insurance database.

D. Patt, C. Enger, D. Corzo, 2014 .

A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.

Wuh-Liang Hwu, Hanna Mandel, H. Mandel, 2006, Jornal de Pediatria.

Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups.

J. Lieberman, J. Yunis, J. Delgado, 1997, Blood.

The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups.

J. Lieberman, J. Yunis, E. Yunis, 1995, Blood.

HLA associations in clozapine-induced agranulocytosis.

J. Lieberman, J. Yunis, J. Yunis, 1995, Blood.

Advances in HLA genetics.

E. Yunis, D. Corzo, M. Salazar, 1995, Experimental and clinical immunogenetics.

Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens In Elderly, Newly Diagnosed Multiple Myeloma Patients

J. Reeves, I. Flinn, R. Neuwirth, 2010 .

NCCN Guidelines Panel: Non-Hodgkin's Lymphomas On behalf of Millennium Pharmaceuticals, Inc., I respectfully request the NCCN Non- Hodgkin's Lymphomas Guidelines Panel to review the enclosed data on the use of VELCADE

D. Corzo, 2011 .

Phase 3b UPFRONT Study: Interim Results From a Community Practice-Based Prospective Randomized Trial Evaluating Three Bortezomib-Based Regimens in Elderly, Newly Diagnosed Multiple Myeloma Patients.

J. Reeves, I. Flinn, R. Neuwirth, 2009 .

The treatment patterns, efficacy, and safety of nab®-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis

D. Patt, C. Enger, D. Corzo, 2015, BMC Cancer.

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease.

G. Herman, R. C. Rogers, T. Voit, 2006, The Journal of pediatrics.

Clinical features of late‐onset Pompe disease: A prospective cohort study

A. Pestronk, L. H. van den Berg, K. Jaffe, 2008, Muscle & nerve.

Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.

P. Kishnani, D. Corzo, R. Pomponio, 2007, Molecular genetics and metabolism.

Pharmacodynamic Activity of the Novel Neurokinin-3 Receptor Antagonist SJX-653 in Healthy Men

R. Thieroff-Ekerdt, D. Corzo, M. Boyce, 2020, The Journal of clinical endocrinology and metabolism.

Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease.

J. Phillips, Yuan-Tsong Chen, A. Fogo, 2004, Pediatrics.

T.O.4 Safety and efficacy results from a randomized, double-blind, placebo-controlled study of alglucosidase alfa for the treatment of Pompe disease in juveniles and adults

A. Pestronk, J. Florence, P. Laforêt, 2008, Neuromuscular Disorders.

HSP70-2 9.0 kb variant is in linkage disequilibrium with the HLA-B and DRB1* alleles associated with clozapine-induced agranulocytosis.

J. Lieberman, J. Yunis, E. Yunis, 1994, The Journal of clinical psychiatry.